| |
 |
|
Class Information
Number: 514/8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Glycoprotein (carbohydrate containing)
Description: Subject matter which contains a carbohydrate or derivative thereof attached to the peptide.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6319493 |
Treatment of neoplastic disease with interleukin-10 |
Nov. 20, 2001 |
| 6319502 |
Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
Nov. 20, 2001 |
| 6319517 |
Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation |
Nov. 20, 2001 |
| 6319894 |
Complexes and combinations of fetuin with therapeutic agents |
Nov. 20, 2001 |
| 6319895 |
Lactoferrin tablets |
Nov. 20, 2001 |
| 6319896 |
Method of solubilizing, purifying, and refolding protein |
Nov. 20, 2001 |
| 6315995 |
Methods for treating an ischemic disorder and improving stroke outcome |
Nov. 13, 2001 |
| 6312680 |
Methods of treatment using cytokine synthesis inhibitory factor |
Nov. 6, 2001 |
| 6309633 |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same |
Oct. 30, 2001 |
| 6309646 |
Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates |
Oct. 30, 2001 |
| 6310039 |
Antineoplastic conjugates of transferrin, albumin and polyethylene glycol |
Oct. 30, 2001 |
| 6306395 |
Fas antigen derivatives |
Oct. 23, 2001 |
| 6306823 |
Purified new epididymal forward motility protein and a process for isolation of the said epididymal forward motility protein useful as a fertility promoter/blocker |
Oct. 23, 2001 |
| 6306824 |
Uses of lipopolysaccharide binding protein |
Oct. 23, 2001 |
| 6306900 |
Enteric coated pharmaceutical compositions |
Oct. 23, 2001 |
| 6303113 |
Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes |
Oct. 16, 2001 |
| 6303114 |
IL-12 enhancement of immune responses to T-independent antigens |
Oct. 16, 2001 |
| 6303126 |
Treatment of fibrosis by HGF |
Oct. 16, 2001 |
| 6303127 |
Treatment of disease states |
Oct. 16, 2001 |
| 6303572 |
Control of acidic gut syndrome |
Oct. 16, 2001 |
| 6303580 |
Cyclitol Containing carbohydrates from human tissue which regulate lipogenic activity |
Oct. 16, 2001 |
| 6299870 |
Mutant human interferons |
Oct. 9, 2001 |
| 6300308 |
Methods and compositions for inducing autoimmunity in the treatment of cancers |
Oct. 9, 2001 |
| 6300309 |
Method and composition for the treatment of osteoporosis |
Oct. 9, 2001 |
| 6296844 |
Asialocytokines and treatment of liver disease |
Oct. 2, 2001 |
| 6297028 |
IL-2R-associated polypeptide and DNA molecules coding therefor |
Oct. 2, 2001 |
| 6294164 |
Natural killer cell enhancing factor C |
Sep. 25, 2001 |
| 6294517 |
Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
Sep. 25, 2001 |
| 6294523 |
Extended type 1 chain glycosphingolipids as tumor-associated antigens |
Sep. 25, 2001 |
| 6294540 |
Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
Sep. 25, 2001 |
| 6290948 |
Method of treating sepsis and ARDS using chamohine beta-10 |
Sep. 18, 2001 |
| 6290972 |
Method of augmenting a vaccine response by administering CD40 ligand |
Sep. 18, 2001 |
| 6287606 |
Methods of enhancing wound healing and tissue repair |
Sep. 11, 2001 |
| 6288028 |
BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
Sep. 11, 2001 |
| 6288031 |
Method for reducing extravasation of effector cells |
Sep. 11, 2001 |
| 6284236 |
Cytokine that induces apoptosis |
Sep. 4, 2001 |
| 6284237 |
Methods of treatment using IL-6 |
Sep. 4, 2001 |
| 6284730 |
Methods useful in the treatment of bone resorption diseases |
Sep. 4, 2001 |
| 6280729 |
Preparation of factor IX |
Aug. 28, 2001 |
| 6280975 |
IL-6 mutein and DNA encoding thereto |
Aug. 28, 2001 |
| 6281191 |
Compositions and methods for treating hepatitis-C |
Aug. 28, 2001 |
| 6281192 |
Mucin containing ophthalmic preparations |
Aug. 28, 2001 |
| 6277812 |
Methods for inhibiting TGF-.beta. activity |
Aug. 21, 2001 |
| 6277817 |
Human lactoferrin |
Aug. 21, 2001 |
| 6277829 |
Process for preparing of aqueous formulation for opthalmic use |
Aug. 21, 2001 |
| 6274135 |
Method of using IL-11 for inflammation associated with acute pancreatitis |
Aug. 14, 2001 |
| 6274547 |
Methods comprising the use of human interleukin-11 receptor proteins |
Aug. 14, 2001 |
| 6274550 |
Azaftig, a proteoglycan for monitoring cachexia and for control of obesity |
Aug. 14, 2001 |
| 6274568 |
Compounds for altering cell surface sialic acids and methods of use therefor |
Aug. 14, 2001 |
| 6271200 |
Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
Aug. 7, 2001 |
|
|
|
